Abstract
The recent literature contains numerous studies of glycolipids and glycoproteins of tumor cells. Diverse changes in chemical composition and/or organization have been found in tumor cells of various sources: chemical and viral transformation in vitro and tumor tissues in vivo.1,2 They have incited wide interest although little is known about their exact biological significance. Theoretically, they may lead to an understanding of some essential problems, such as the malignant behavior of tumor cells and the role of gene mutation in the development of cancer. In addition, their practical potentialities as tumor markers has also been extensively explored.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Hakomori. Monoclonal antibodies directed to cell-surface carbohydrates, in “Monoclonal antibodies and functional cell lines.” pp. 67–100. R.H. Kennet, K.B. Bechtol, and T.J. McKaarn ed., Plenum Publishing, New York. (1984).
R.F. Irie, L.L. Sze, and R.E. Saxton. Human antibody to OFA-1, a tumor antigen, produced in vitro by Epstein- Barr virus-transformed human B-lymphoid cell lines. Proc. Natl. Acad. Sci. USA 79:5666–5670, (1982).
Shun-zhang Yu. Epidemiology of primary liver cancer, in “Subclinical Hepatocellular Carcinoma,” Z.Y. Tang ed., pp. 189–211. China Academic Publishers, Beijing, Spring-Verlag, Berlin. (1985).
Zhao-you Tang. A new concept of the natural history of AFP positive hepatocellular carcinoma, in “Subclinical Hepatocellular Carcinoma,” Z.Y. Tang ed., pp. 171–177. China Academic Publishers, Beijing, Spring-Verlag, Berlin. (1985).
R.O. Brady, C. Borek, and R.M. Bradley. Composition and synthesis of gangliosi.de in rat hepatocyte and hepatoma cell lines. J. Biol. Chem. 244:6552–6554, (1969).
S. Hakomori. Change of glycolipid pattern in Morris hepatoma 5123 and 7800. Cancer Research, 30:2930–2936, (1970).
E.V. Dyatlovitskaya. Gangliosides of rat liver and hepatoma 27. Biochimya (Russ), 39: 552–556, (1974).
A.M. Dnistiran, V.P. Skipski, M. Barclay, and C.C. Stock. Alterations in glycosphingolipids of plasma membranes from Morris hepatoma 5132TC. Cancer Res., 37:2182–2187, (1977).
E.V. Dyalovitskaya, A.M. Novikov, N.P. Gorkova, and L.D. Bergelson. Gangliosides of hepatoma 27, normal and regenerating rat liver. Eur. J. Biochem., 67:357–364, (1976).
R.P. Van Hoeven and P. Emmelot. Plasma membrane lipids of normal and neoplastic tissues, in “Tumor lipids: Biochemistry and Metabolism”, pp. 126–138. E. Wood ed., Amer. Oil Chemist’s Soc. Press: Illinois, (1973).
W.D. Merritt, C.L. Richardson, T.W. Keenan, and D.J. Morre. Gangliosides of liver tumors induced by N-2- fluorenylacetamide I. Ganglioside alterations in liver tumorigenesis and normal development. J. Nat’l. Cancer Inst., 60: 1313–1327, (1978).
W.D. Merritt, C.L. Richardson, T.W. Keenan, and D.J. Morre. Ganglioside of liver tumors induced by N-2- fluorenylacetamide II. Alterations in biosynthetic enzymes. J. Nat’l. Cancer Inst., 60: 1329–1337, (1978)
D.J. Morre, T.M. Kloppel, W.D. Merritt, and T.W. Keenan. Glycolipids as indicators of tumorigenesis. J. Supramol. Struct., 9:157–177, (1978).
J. Kawanami. Lipids of cancer tissue III. Glycolipids of human hepatoma tissue. Jap. J. Exp. Med., 38:11–18, (1968).
Tanno Munehiko, et al. Copmparison of gangiosides pattern in cirrhotic liver and liver cell cancer. Liver, (Japan) 23:684, (1982).
Neng-hua Gho and Tian-Jue Gu. Ganglioside pattern in hepatoma. Acta. Acad. Med. Primae, Shangai, 12: 149–151, (1985).
Zheng-mei Zhu, De-sheng Zhang, Ji-ding Yuan, and Tian-jue Gu. The distribution pattern of ganglioside in normal, embryonic, and cancerous human liver. Acta. Acad. Med. Primae., Shangai, 18:234–236, (1983).
V.P. Walter, T.M. Kloppel, I.G. Deimling, and D.J. Morre. Alterations in neutral glycosphingolipids from transplantable hepatomas and in sera of rats bearing transplantable hepatomas. Cancer Biochem. Biophys., 4: 145–151, (1980).
T. Momoi, S. Ando, and Y. Magai. High resolution preparative column chromatographic system for ganglioside DEAE-Sephadex and a new porous silica, Iatrobeads. Biochim. Biophys. Acta, 441:448–497, (1976).
R.W. Ledeen and R.K. Yu. Gangliosides: structure, isolation, and analysis, in “Methods on Enzymology” V. Ginsberg ed., 83:139–191, (1982).
S. Hakomori. Tumor associated glycolipid antigens defined by monoclonal antibodies. Bull. Cancer, 70:118–126, (1983).
Neng-hua Guo and Tian-Jue Gu. Ganglioside pattern in hepatocellular hepatoma. Acta Biochim. Biophys. Sinica, 17:538–543, (1985).
Xia-juan Xia, Zhao-chun Cui, and Tian-Jue Gu. Isolation and purification of the hepatoma associated ganglioside. Chinese Biochem J. 1(2):13–17, (1985).
Xia-juan Xia, Zhao-chun Cui, and Tian-Jue Gu. Composition and carbohydrate sequence analysis of the hepatoma associated ganglioside. Acta Biochim. Biophys. Sinica, 17:615–623, (1985).
Xia-juan Xia, De-sheng Zhang, Zhao-chun Cui, Lan-nian Zhang, and Tian-Jue Gu. Permethylation analysis of hepatoma associated ganglioside. Acta Biochim. Biophys. Sinica, 17:635–642, (1985).
M. Inbar and L. Sachs. Interaction of the carbohydrate- binding protein Concanavalin A with normal and transformed cells. Proc. Nat’1. Acad. Sci. USA, 63:1418–1425, (1969).
L.D. Berman. Lack of correlation between growth characteristics, agglutinability by plant lectins and the malignant phenotype. Int. J. Cancer, 15: 973–979, (1975).
Zheng-Mei Zhu and Tian-Jue Gu. The agglutinative effect of Con A and PHA on normal, embryonic, and tumor cells. Chinese J. Cell Biol., 4(l):35–37, (1982).
Zheng-Mei Zhu and Tian-Jue Gu. The function of cell membrane in cell agglutination. Chinese J. Cell Biol. 4(2):16–19. (1982).
Zheng-Mei Zhu and Tian-Jue Gu. Con A receptors on normal liver and hepatoma cells. Chinese J. Cell Biol. 4(3): 21–24, (1982).
Zheng-Mei Zhu and Tian-Jue Gu. Agglutinin and cell agglutination IV characterization of Concanavalin A receptors on hepatoma cells. Acta Biochim. Biophys. Sinica, 14:295–301, (1982).
Xie-lin Ren, Jun-Cai Lin, and Tian-jue Gu. Comparison of soybean agglutinin receptors on hepatoma and normal mouse liver cells. Tumor, 2(5):4–6, (1982).
J.U. Baenziger and Y. Maynard. Human hepatic lectin purification. J. Biol. Chem., 225: 4 607–4613, (1980).
A G. Morell, G. Gregoriadis, and I.H. Scheinberg. The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem., 246:1461–1467, (1971).
G. Uhlenbruck, J. Beuth, and V. Weidtman. Liver lectins: mediators for metastases? Experentia, 39: 1314–1315, (1983).
S.H. Berondes. Lectins: their multiple endogenous cellular functions. Ann. Rev. Biochem., 50: 207–231, (1981).
Hui-ren Zhou, Zheng-Mei Zhu and Tian-Jue Gu. B- galactoside specific lectins in normal anmd cancer bearing rat liver cells. Acta Acad. Med. Primae, Shangai, 11:361–364, (1984).
J.H. Jandel and J.H. Katz. The plasma-to-cell cyle of transferrin. J. Chin. Invest. 42:314–326, (1963).
I.S. Trowbridge, R. A. Newman, and D.L. Domingo. Transferrin Receptors: structure and function. Biochem. Pharmcol., 33:925–932, (1984).
W.P. Faulk and G.M.P. Galbraith. Trophoblast transferrin and transferrin receptor in the host parasite relationship of human pregnancy. Proc. Royal Soc. Lond. (Biol), 204:83–97, (1979).
G.M. Galbraith, R.H. Galbraith, and W.P. Faulk. Transferrin binding by human lymphoblastoid cell lines and other transformed cells. Cell Immun., 49:215–222, (1980).
R. Sutherland, D. Delia, C. Schneider, R. Newman, J. Kemshead, and M. Greaves. Ubiquitous cell surface glycoproteins on tumor cells is proliferation associated receptor for transferrin. Proc. Nat’1. Acad. Sci. USA, 78 4515–4519, (1981).
D. Delia, M.F. Greaves, R. Newman. Modulation of Tleukemic cell phenotype with phorbol ester. Int. J. Cancer, Int. J. Cancer, 29; 23–31, (1982).
P. Reichard. From deoxynucleotides to DNA synthesis. Federation Proc., 37:9–14, (1978).
L. Vodinelich, R Sutherland, C. Schneider, R. Newman, and M. Greaves. Receptor for transferrin may be a target structure for natural killer cells. Proc. Natl. Acad Sci. USA, 80:835–839, (1983).
R. J. Stockert, A. G. Morell and I.H. Scheinberg. Hepatic binding protein: The protective role of its sialic acid residues. Science 197:66–68, (1977).
Hui-ren Zhou, Jin-yu Ma, and Tian-Jue Gu. Detection of transferrin receptor on cancer cell mebrane and the preparation of transferrin receptor and its antibody. Acta. Acad Med. Primae Shangii 11:165, (1984).
Hui-ren Zhou, Jian-nan Yeh, and Tian-Jue Gu. The uptake of 125I-transferrin in N-nitrosurea induced rat mammary tumor. In press.
Yu-ding Kuo, Z.Y. Tang, Z.Y. Lin, Z.S. Ma, K.G. Cheng, and W.Y. Yhao. Observation of radioimmunodetection of 131I-anti AFP in nude mice bearing human hepatocellular carcinoma. Tumor, 51:4–6, (1985).
D. Yu and Z.Y. Tang. Radioscanning of hepatocellular cancer using 131I-anti-acid ferrin antibody. Thesis for M.S. degree, (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Gu, TJ. (1988). Glycolipids and Glycoproteins in Plasma Membrane of Hepatocellular Cancer. In: Wu, A.M., Adams, L.G. (eds) The Molecular Immunology of Complex Carbohydrates. Advances in Experimental Medicine and Biology, vol 228. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1663-3_28
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1663-3_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8923-4
Online ISBN: 978-1-4613-1663-3
eBook Packages: Springer Book Archive